Cerebrospinal fluid protein biomarker panel for assessment of neurotoxicity induced by kainic acid in rats

Toxicological Sciences

Volumn 130, Issue 1, 2012, Pages 158-167

  Glushakova, Olena Y ^a   Jeromin, Andreas ^a   Martinez, Juan ^a   Johnson, Danny ^a   Denslow, Nancy ^b   Streeter, Jackson ^a   Hayes, Ronald L ^a   Mondello, Stefania ^a  

^a BANYAN BIOMARKERS INC   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Biomarkers; CSF; GFAP; Kainic acid; Neurotoxicity; SBDP120; SBDP145; SBDP150; UCH L1

Indexed keywords

BIOLOGICAL MARKER; FLUORESCENT DYE; FLUORO JADE C; FODRIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; HYDROLASE; KAINIC ACID; PROTEIN SBDP120; PROTEIN SBDP145; PROTEIN SBDP150; UBIQUITIN CARBOXY TERMINAL HYDROLASE 1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENTORHINAL CORTEX; EXCITOTOXICITY; EXTRACELLULAR MATRIX; GLIA; GLIOSIS; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; MALE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE DEGENERATION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIMARY SOMATOSENSORY CORTEX; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN EXPRESSION; RAT; RISK ASSESSMENT; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID ANTAGONISTS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; KAINIC ACID; MALE; NEUROTOXICITY SYNDROMES; RATS; RATS, SPRAGUE-DAWLEY; SPECTRIN; UBIQUITIN THIOLESTERASE; UP-REGULATION;

EID: 84867767110     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs224     Document Type: Article

References (76)

1. Araujo, I. M., Gil, J. M., Carreira, B. P., Mohapel, P., Petersen, A., Pinheiro, P. S., Soulet, D., Bahr, B. A., Brundin, P., and Carvalho, C. M. (2008). Calpain activation is involved in early caspase-independent neurodegeneration in the hippocampus following status epilepticus. J. Neurochem. 105, 666-676.
2. Arnaoutakis, G. J., George, T. J., Wang, K. K., Wilson, M. A., Allen, J. G., Robinson, C. W., Haggerty, K. A., Weiss, E. S., Blue, M. E., Talbot, C. C., Jr., et al. (2011). Serum levels of neuron-specific ubiquitin carboxyl-terminal esterase-L1 predict brain injury in a canine model of hypothermic circulatory arrest. J. Thorac. Cardiovasc. Surg. 142, 902-910.e1.
3. Bajda, M., Guzior, N., Ignasik, M., and Malawska, B. (2011). Multi-target-directed ligands in Alzheimer's disease treatment. Curr. Med. Chem. 18, 4949-4975.
4. Barry, J. D., and Wills, B. K. (2011). Neurotoxic emergencies. Neurol. Clin. 29, 539-563.
5. Benskey, M., Behrouz, B., Sunryd, J., Pappas, S. S., Baek, S. H., Huebner, M., Lookingland, K. J., and Goudreau, J. L. (2012). Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology 33, 321-331.
6. Berger, R. P., Hayes, R. L., Richichi, R., Beers, S. R., and Wang, K. K. (2012). Serum concentrations of ubiquitin C-terminal hydrolase-L1 and alphaII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. J. Neurotrauma 29, 162-167.
7. Bi, X., Chang, V., Siman, R., Tocco, G., and Baudry, M. (1996). Regional distribution and time-course of calpain activation following kainate-induced seizure activity in adult rat brain. Brain Res. 726, 98-108.
8. Bi, X., Chen, J., and Baudry, M. (1997). Developmental changes in calpain activity, GluR1 receptors and in the effect of kainic acid treatment in rat brain. Neuroscience 81, 1123-1135.
9. Blyth, B. J., Farahvar, A., He, H., Nayak, A., Yang, C., Shaw, G., and Bazarian, J. J. (2011). Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury. J. Neurotrauma 28, 2453-2462.
10. Brophy, G. M., Mondello, S., Papa, L., Robicsek, S. A., Gabrielli, A., Tepas 3rd J., Buki, A., Robertson, C., Tortella, F. C., Hayes, R. L., et al. (2011). Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. J. Neurotrauma 28, 861-870.
11. Brophy, G. M., Pineda, J. A., Papa, L., Lewis, S. B., Valadka, A. B., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Tepas, J. J., 3rd, et al. (2009). alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. J. Neurotrauma 26, 471-479.
12. Cai, Y., Zhu, H. X., Li, J. M., Luo, X. G., Patrylo, P. R., Rose, G. M., Streeter, J., Hayes, R., Wang, K. K., Yan, X. X., et al. (2012). Age-related intraneuronal elevation of αII-spectrin breakdown product SBDP120 in rodent forebrain accelerates in 3×Tg-AD Mice. PLoS ONE 7, e37599.
13. Cardali, S., and Maugeri, R. (2006). Detection of alphaII-spectrin and breakdown products in humans after severe traumatic brain injury. J. Neurosurg. Sci. 50, 25-31.
14. Cox, C. D., West, E. J., Liu, M. C., Wang, K. K., Hayes, R. L., and Lyeth, B. G. (2008). Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injury. J. Neurotrauma 25, 1355-1365.
15. Crespo-Biel, N., Camins, A., Canudas, A. M., and Pallàs, M. (2010). Kainate-induced toxicity in the hippocampus: Potential role of lithium. Bipolar Disord. 12, 425-436.
16. Dietrich, J. (2010). Chemotherapy associated central nervous system damage. Adv. Exp. Med. Biol. 678, 77-85.
17. Dietrich, J., Han, R., Yang, Y., Mayer-Pröschel, M., and Noble, M. (2006). CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J. Biol. 5, 22.
18. Dong, X. X., Wang, Y., and Qin, Z. H. (2009). Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases. Acta Pharmacol. Sin. 30, 379-387.
19. Doshi, S., and Lynch, D. R. (2009). Calpain and the glutamatergic synapse. Front. Biosci. (Schol. Ed). 1, 466-476.
20. Doyle, K. M., Kennedy, D., Gorman, A. M., Gupta, S., Healy, S. J., and Samali, A. (2011). Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders. J. Cell. Mol. Med. 15, 2025-2039.
21. Ehrenreich, H., Kästner, A., Weissenborn, K., Streeter, J., Sperling, S., Wang, K. K., Worthmann, H., Hayes, R. L., von Ahsen, N., Kastrup, A., et al. (2011). Circulating damage marker profiles support a neuroprotective effect of erythropoietin in ischemic stroke patients. Mol. Med. 17, 1306-1310.
22. Elliott, E. M., Mattson, M. P., Vanderklish, P., Lynch, G., Chang, I., and Sapolsky, R. M. (1993). Corticosterone exacerbates kainate-induced alterations in hippocampal tau immunoreactivity and spectrin proteolysis in vivo. J. Neurochem. 61, 57-67.
23. Farkas, O., Polgár, B., Szekeres-Barthó, J., Dóczi, T., Povlishock, J. T., and Büki, A. (2005). Spectrin breakdown products in the cerebrospinal fluid in severe head injury-preliminary observations. Acta Neurochir. (Wien). 147, 855-861.
24. Fujikawa, D. G. (2005). Prolonged seizures and cellular injury: Understanding the connection. Epilepsy Behav. 7(Suppl. 3), S3-11.
25. Gilliams-Francis, K. L., Quaye, A. A., and Naegele, J. R. (2003). PARP cleavage, DNA fragmentation, and pyknosis during excitotoxin-induced neuronal death. Exp. Neurol. 184, 359-372.
26. Grant, K. S., Burbacher, T. M., Faustman, E. M., and Gratttan, L. (2010). Domoic acid: Neurobehavioral consequences of exposure to a prevalent marine biotoxin. Neurotoxicol. Teratol. 32, 132-141.
27. Grill, M. F., and Maganti, R. K. (2011). Neurotoxic effects associated with antibiotic use: Management considerations. Br. J. Clin. Pharmacol. 72, 381-393.
28. Haddad, P. M., and Dursun, S. M. (2008). Neurological complications of psychiatric drugs: Clinical features and management. Hum. Psychopharmacol. 23(Suppl. 1), 15-26.
29. Hopkins, K. J., Wang, G., and Schmued, L. C. (2000). Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res. 864, 69-80.
30. Hynd, M. R., Scott, H. L., and Dodd, P. R. (2004). Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem. Int. 45, 583-595.
31. Jansen, C. E., Cooper, B. A., Dodd, M. J., and Miaskowski, C. A. (2011). A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients. Support. Care Cancer 19, 1647-1656.
32. Kim, K., Lee, S. G., Kegelman, T. P., Su, Z. Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P., et al. (2011). Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics. J. Cell. Physiol. 226, 2484-2493.
33. Kochanek, P. M., Berger, R. P., Bayir, H., Wagner, A. K., Jenkins, L. W., and Clark, R. S. (2008). Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr. Opin. Crit. Care 14, 135-141.
34. Kondratyev, A., and Gale, K. (2004). Latency to onset of status epilepticus determines molecular mechanisms of seizure-induced cell death. Brain Res. Mol. Brain Res. 121, 86-94.
35. Lewis, S. B., Velat, G. J., Miralia, L., Papa, L., Aikman, J. M., Wolper, R. A., Firment, C. S., Liu, M. C., Pineda, J. A., Wang, K. K., et al. (2007). Alpha-II spectrin breakdown products in aneurysmal subarachnoid hemorrhage: A novel biomarker of proteolytic injury. J. Neurosurg. 107, 792-796.
36. Liu, M. C., Akinyi, L., Scharf, D., Mo, J., Larner, S. F., Muller, U., Oli, M. W., Zheng, W., Kobeissy, F., Papa, L., et al. (2010). Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats. Eur. J. Neurosci. 31, 722-732.
37. Menon, K. N., Steer, D. L., Short, M., Petratos, S., Smith, I., and Bernard, C. C. (2011). A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases. Mol. Cell Proteomics 10, M110.000042.
38. Mondello, S., Jeromin, A., Buki, A., Bullock, R., Czeiter, E., Kovacs, N., Barzo, P., Schmid, K., Tortella, F. C., Wang, K. K., et al. (2012). Glial neuronal ratio (GNR): A novel index for differentiating injury type in patients with severe traumatic brain injury. J. Neurotrauma 29, 1096-1104.
39. Mondello, S., Papa, L., Buki, A., Bullock, M. R., Czeiter, E., Tortella, F. C., Wang, K. K., and Hayes, R. L. (2011). Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: A case control study. Crit. Care 15, R156.
40. Mondello, S., Robicsek, S. A., Gabrielli, A., Brophy, G. M., Papa, L., Tepas, J., Robertson, C., Buki, A., Scharf, D., Jixiang, M., et al. (2010). αII-Spectrin breakdown products (SBDPs): Diagnosis and outcome in severe traumatic brain injury patients. J. Neurotrauma 27, 1203-1213.
41. Nath, R., Probert, A., Jr., McGinnis, K. M., and Wang, K. K. (1998). Evidence for activation of caspase-3-like protease in excitotoxin- and hypoxia/ hypoglycemia-injured neurons. J. Neurochem. 71, 186-195.
42. Newton, H. B. (2012). Neurological complications of chemotherapy to the central nervous system. Handb. Clin. Neurol. 105, 903-916.
43. O'Callaghan, J. P., and Sriram, K. (2005). Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity. Expert Opin. Drug Saf. 4, 433-442.
44. Papa, L., Akinyi, L., Liu, M. C., Pineda, J. A., Tepas, J. J., 3rd, Oli, M. W., Zheng, W., Robinson, G., Robicsek, S. A., Gabrielli, A., et al. (2010). Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Crit. Care Med. 38, 138-144.
45. Petzold, A. (2005). Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss. J. Neurol. Sci. 233, 183-198.
46. Pike, B. R., Flint, J., Dave, J. R., Lu, X. C., Wang, K. K., Tortella, F. C., and Hayes, R. L. (2004). Accumulation of calpain and caspase-3 proteolytic fragments of brain-derived alphaII-spectrin in cerebral spinal fluid after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 24, 98-106.
47. Pike, B. R., Flint, J., Dutta, S., Johnson, E., Wang, K. K., and Hayes, R. L. (2001). Accumulation of non-erythroid alpha II-spectrin and calpain-cleaved alpha II-spectrin breakdown products in cerebrospinal fluid after traumatic brain injury in rats. J. Neurochem. 78, 1297-1306.
48. Pike, B. R., Zhao, X., Newcomb, J. K., Posmantur, R. M., Wang, K. K., and Hayes, R. L. (1998). Regional calpain and caspase-3 proteolysis of alpha-spectrin after traumatic brain injury. Neuroreport 9, 2437-2442.
49. Pineda, J. A., Lewis, S. B., Valadka, A. B., Papa, L., Hannay, H. J., Heaton, S. C., Demery, J. A., Liu, M. C., Aikman, J. M., Akle, V., et al. (2007). Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury. J. Neurotrauma 24, 354-366.
50. Pivovarova, N. B., and Andrews, S. B. (2010). Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J. 277, 3622-3636.
51. Plunkett, L. M. (2007). Developmental neurotoxicity of industrial chemicals. Lancet 369, 821.
52. Rajdev, S., and Sharp, F. R. (2000). Stress proteins as molecular markers of neurotoxicity. Toxicol. Pathol. 28, 105-112.
53. Rao, D. B., Little, P. B., Malarkey, D. E., Herbert, R. A., and Sills, R. C. (2011). Histopathological evaluation of the nervous system in National Toxicology Program rodent studies: A modified approach. Toxicol. Pathol. 39, 463-470.
54. Ringger, N. C., O'Steen, B. E., Brabham, J. G., Silver, X., Pineda, J., Wang, K. K., Hayes, R. L., and Papa, L. (2004). A novel marker for traumatic brain injury: CSF alphaII-spectrin breakdown product levels. J. Neurotrauma 21, 1443-1456.
55. Rodríguez, M. J., Pugliese, M., and Mahy, N. (2009). Drug abuse, brain calcification and glutamate-induced neurodegeneration. Curr. Drug Abuse Rev. 2, 99-112.
56. Salloway, S., Mintzer, J., Weiner, M. F., and Cummings, J. L. (2008). Disease-modifying therapies in Alzheimer's disease. Alzheimers Dement. 4, 65-79.
57. Schmued, L. C., Albertson, C., and Slikker, W., Jr. (1997). Fluoro-Jade: A novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 751, 37-46.
58. Schmued, L. C., and Hopkins, K. J. (2000). Fluoro-Jade: Novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol. Pathol. 28, 91-99.
59. Schmued, L. C., Stowers, C. C., Scallet, A. C., and Xu, L. (2005). Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res. 1035, 24-31.
60. Seigers, R., Schagen, S. B., Beerling, W., Boogerd, W., van Tellingen, O., van Dam, F. S., Koolhaas, J. M., and Buwalda, B. (2008). Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat. Behav. Brain Res. 186, 168-175.
61. Seigers, R., Schagen, S. B., Coppens, C. M., van der Most, P. J., van Dam, F. S., Koolhaas, J. M., and Buwalda, B. (2009). Methotrexate decreases hippocampal cell proliferation and induces memory deficits in rats. Behav. Brain Res. 201, 279-284.
62. Sheldon, A. L., and Robinson, M. B. (2007). The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Neurochem. Int. 51, 333-355.
63. Siman, R., Roberts, V. L., McNeil, E., Dang, A., Bavaria, J. E., Ramchandren, S., and McGarvey, M. (2008). Biomarker evidence for mild central nervous system injury after surgically-induced circulation arrest. Brain Res. 1213, 1-11.
64. Siman, R., Toraskar, N., Dang, A., McNeil, E., McGarvey, M., Plaum, J., Maloney, E., and Grady, M. S. (2009). A panel of neuron-enriched proteins as markers for traumatic brain injury in humans. J. Neurotrauma 26, 1867-1877.
65. Stewart, A., Collins, B., Mackenzie, J., Tomiak, E., Verma, S., and Bielajew, C. (2008). The cognitive effects of adjuvant chemotherapy in early stage breast cancer: A prospective study. Psychooncology. 17, 122-130.
66. Sun, L., Chen, H., Hu, C., Wang, P., Li, Y., Xie, J., Tang, F., Ba, D., Zhang, X., and He, W. (2011). Identify biomarkers of neuropsychiatric systemic lupus erythematosus by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry combined with weak cation magnetic beads. J. Rheumatol. 38, 454-461.
67. Svetlov, S. I., Prima, V., Kirk, D. R., Gutierrez, H., Curley, K. C., Hayes, R. L., and Wang, K. K. (2010). Morphologic and biochemical characterization of brain injury in a model of controlled blast overpressure exposure. J. Trauma 69, 795-804.
68. Tsai, G., and Coyle, J. T. (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annu. Rev. Med. 49, 173-184.
69. Vanderklish, P. W., and Bahr, B. A. (2000). The pathogenic activation of calpain: A marker and mediator of cellular toxicity and disease states. Int. J. Exp. Pathol. 81, 323-339.
70. Wang, Y., and Qin, Z. H. (2010). Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402.
71. Warren, M. W., Larner, S. F., Kobeissy, F. H., Brezing, C. A., Jeung, J. A., Hayes, R. L., Gold, M. S., and Wang, K. K. (2007). Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathol. 114, 277-286.
72. Wefel, J. S., Lenzi, R., Theriault, R. L., Davis, R. N., and Meyers, C. A. (2004). The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer 100, 2292-2299.
73. Wefel, J. S., and Schagen, S. B. (2012). Chemotherapy-related cognitive dysfunction. Curr. Neurol. Neurosci. Rep. 12, 267-275.
74. Weiss, E. S., Wang, K. K., Allen, J. G., Blue, M. E., Nwakanma, L. U., Liu, M. C., Lange, M. S., Berrong, J., Wilson, M. A., Gott, V. L., et al. (2009). Alpha II-spectrin breakdown products serve as novel markers of brain injury severity in a canine model of hypothermic circulatory arrest. Ann. Thorac. Surg. 88, 543-550.
75. Yan, X.-X., and Jeromin, A. (2012). Spectrin breakdown products (SBDPs) as potential biomarkers for neurodegenerative diseases. Curr. Transl. Geriatr. Exp. Gerontol. Rep. 1, 85-93.
76. Zheng, X. Y., Zhang, H. L., Luo, Q., and Zhu, J. (2011). Kainic acid-induced neurodegenerative model: Potentials and limitations. J. Biomed. Biotechnol. 2011, 457079.